TY - JOUR
T1 - Improving inclusivity in UK clinical trials through good practice in the collection and use of ethnicity data
T2 - recommendations from the INCLUDED study
AU - Sohanpal, Ratna
AU - Newton, Sian
AU - Akudo, Percy
AU - Colligan, Grainne
AU - Crosse, Annette
AU - Durham, Ceri
AU - Green, Heidi
AU - Hopewell, Sally
AU - Jackson, Tracy
AU - Jayacodi, Sandra
AU - Khan, Imran
AU - Kwaku-Odoi, Charles
AU - Lam, Emily
AU - Lancaster, Gillian A
AU - Lawton, Sarah Ann
AU - Makita, Meiko
AU - Mistry, Kirit
AU - Mohammed, Aliya
AU - Ratton, Beatriz L
AU - Smith, Jo
AU - Sunga, Ria
AU - Thomson, Ann
AU - Treweek, Shaun
AU - Williams, Clancy
AU - Mistry, Manoj
AU - Eldridge, Sandra
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY. Published by BMJ Group. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
PY - 2026/7/14
Y1 - 2026/7/14
N2 - Ethnicity data are essential in understanding how different groups are impacted by different treatments/healthcare interventions, but more work is needed in how these data should be collected, handled and reported in trials to address distrust among marginalised ethnic groups towards healthcare research. To do this, researchers need effective training and opportunities to engage with communities from a diverse range of ethnicities. Developing guidance on how to meaningfully involve diverse ethnic groups in all stages of a trial including planning the collection of ethnicity data is one way to improve the impact of clinical trial results and ensure these groups can access equitable healthcare.Our collaborative work between health researchers and diverse ethnic communities produced 13 initial recommendations aimed at academic health researchers to change their practice involving diverse ethnic communities in areas from trial design through to reporting. The first four recommendations are concerned with the planning stage of the trial, the fifth with how researchers interact with funding bodies. Recommendations 6, 7 and 8 are relevant to data collection during trial set up, and recommendations 9, 10 and 11 focus on training and responsibility during the trial set up and the trial conduct stage. Recommendations 12 and 13 cover reporting.The recommendations will benefit from piloting but have the potential to help trial teams make their research more inclusive with regard to ethnicity, which in turn will support more representative, equitable and impactful research.
AB - Ethnicity data are essential in understanding how different groups are impacted by different treatments/healthcare interventions, but more work is needed in how these data should be collected, handled and reported in trials to address distrust among marginalised ethnic groups towards healthcare research. To do this, researchers need effective training and opportunities to engage with communities from a diverse range of ethnicities. Developing guidance on how to meaningfully involve diverse ethnic groups in all stages of a trial including planning the collection of ethnicity data is one way to improve the impact of clinical trial results and ensure these groups can access equitable healthcare.Our collaborative work between health researchers and diverse ethnic communities produced 13 initial recommendations aimed at academic health researchers to change their practice involving diverse ethnic communities in areas from trial design through to reporting. The first four recommendations are concerned with the planning stage of the trial, the fifth with how researchers interact with funding bodies. Recommendations 6, 7 and 8 are relevant to data collection during trial set up, and recommendations 9, 10 and 11 focus on training and responsibility during the trial set up and the trial conduct stage. Recommendations 12 and 13 cover reporting.The recommendations will benefit from piloting but have the potential to help trial teams make their research more inclusive with regard to ethnicity, which in turn will support more representative, equitable and impactful research.
KW - Delivery of Health Care
KW - Methods
KW - QUALITATIVE RESEARCH
UR - https://www.scopus.com/pages/publications/105044627641
U2 - 10.1136/bmjebm-2025-114429
DO - 10.1136/bmjebm-2025-114429
M3 - Article
C2 - 42448444
AN - SCOPUS:105044627641
SN - 2515-446X
JO - BMJ Evidence-Based Medicine
JF - BMJ Evidence-Based Medicine
ER -